No Data
Guosen: In 2024, the overall stable growth of the november 11 shopping festival-related e-commerce promotion, with intensified differentiation of beauty brands.
As of October 30, 2024, the total sales of november 11 shopping festival-related reached 845 billion (including comprehensive e-commerce monitoring period: October 14-October 30, live e-commerce monitoring period: October 8-October 30), refreshing the historical sales record for October.
Guangdong Marubi Biotechnology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Guangdong Marubi Biotechnology (603983): Q3 net profit attributable to parent up by 44%, steadily launching new products, l product performance impressive.
Investment Highlights 24Q3 Performance continues to grow at a high rate, and profitability remains at a high level. (1) 24Q1-Q3: Revenue 1.952 billion, YoY +27.07%, net income attributable to shareholders 0.239 billion, YoY +37.38%.
Guangdong Marubi Biotechnology (603983): Rapid growth in cosmetics, steadily improving profitability.
Reviewing the event, the company released the third quarter report for the year 2024, with a revenue of 1.95 billion yuan, a year-on-year increase of +27.1%; net income attributable to the parent company was 0.24 billion yuan, a year-on-year increase of +37.4%. In Q3 2024, the company achieved...
Guangdong Marubi Biotechnology (603983): Q3 dual-brand online high growth Optimizing the structure to drive profit growth Focus on the november 11 shopping festival-related opportunity beyond expectations.
Event: Guangdong Marubi Biotechnology disclosed its Q3 24 performance: Q1-3 24: revenue of 1.952 billion yuan, +27% year-on-year, net income attributable to the parent company of 0.239 billion yuan, +37% year-on-year; Q3 24: revenue of 0.6 billion yuan, +26% year-on-year.
Guangdong Marubi Biotechnology (603983): The gross margin continues to maintain an increasing trend year-on-year, and sales remain stable in the off-season.
The core view of the company's Q3 quarterly revenue was 0.6 billion yuan, up 25.8% from the previous quarter, accelerating from 18.58% in Q2. Net income attributable to the parent company was 0.062 billion yuan, up 44.3%, and non-net income attributable to the parent company was 0.06 billion yuan, up 56%.
No Data
No Data